KAPA Latest Press Releases

-- July 22, 2026 --

Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer Business Wire 8:35 AM

-- July 15, 2026 --

Kairos Pharma Reports Breakthrough Interim Safety Data in Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer Patients - Targeting a $10 Billion Drug Resistance Market Business Wire 8:30 AM

-- June 4, 2026 --

Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders Business Wire 8:00 AM

-- May 14, 2026 --

Kairos Pharma Receives GHP Magazine's Healthcare & Pharmaceutical Award Business Wire 8:00 AM

-- May 8, 2026 --

Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings Business Wire 4:30 PM

-- April 28, 2026 --

KAPA Investors Have Opportunity to Join Kairos Pharma, Ltd. Fraud Investigation with the Schall Law Firm Globe Newswire 11:10 PM

-- April 15, 2026 --

Kairos Pharma Recognized with Pinnacle Award for Excellence in Healthcare Innovation Business Wire 9:00 AM

-- April 12, 2026 --

Kairos Pharma Investor News: Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation - KAPA Business Wire 3:00 PM

-- April 11, 2026 --

Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation - KAPA Business Wire 7:51 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software